Coty (COTY)
(Delayed Data from NYSE)
$7.70 USD
-0.12 (-1.53%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $7.70 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$7.70 USD
-0.12 (-1.53%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $7.70 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth D Momentum C VGM
Zacks News
Nu Skin (NUS) Set to Report Q2 Earnings: What to Expect?
by Zacks Equity Research
Nu Skin's (NUS) Q2 results are likely to reflect the impacts of macroeconomic challenges, including inflation and adverse currency fluctuations.
Inter Parfums (IPAR) Q2 Earnings in the Cards: Things to Note
by Zacks Equity Research
Inter Parfums' (IPAR) second-quarter performance is likely to reflect strong momentum in the fragrance market, supported by robust sales from its new licenses. High SG&A costs are a threat.
Monster Beverage's (MNST) Q2 Earnings Coming Up: Things to Note
by Zacks Equity Research
Monster Beverage's (MNST) second-quarter 2024 results are likely to reflect gains from strength in its energy drinks category and product launches.
B&G Foods' (BGS) Q2 Earnings in the Cards: Factors to Watch
by Zacks Equity Research
B&G Foods' (BGS) Q2 results are likely to reflect the impacts of category-wide challenges across the food industry and high SG&A costs.
Can Molson Coors' (TAP) Strategies Outrun Inflation Woes in Q2?
by Zacks Equity Research
Molson Coors' (TAP) strategic investments and premiumization efforts drive robust growth amid industry challenges and inflationary pressures. Let us see how the Q2 performance is likely to have been.
Medifast (MED) Q2 Earnings in the Cards: Factors to Watch
by Zacks Equity Research
Medifast's (MED) Q2 results are likely to reflect customer acquisition challenges stemming from the growth of GLP-1 medications in markets.
Factors to Watch Before TreeHouse Foods' (THS) Q2 Earnings
by Zacks Equity Research
TreeHouse Foods' (THS) Q2 results are likely to reflect challenges such as the restart of the broth facility, along with the lag in pricing adjustments to counter cocoa inflation.
Kellanova (K) Q2 Earnings Coming Up: Key Factors to Consider
by Zacks Equity Research
Kellanova's (K) second-quarter performance is likely to reflect the impacts of elevated inflation rates and industry-wide elasticities. Unfavorable foreign currency rates pose a threat.
What's in Store for Church & Dwight's (CHD) Q2 Earnings Report?
by Zacks Equity Research
Church & Dwight's (CHD) robust portfolio built through innovation, new products, and acquisitions positions it well for Q2 earnings amid escalated marketing expenses and inflationary headwinds.
Tyson Foods (TSN) Q3 Earnings in the Cards: Things to Note
by Zacks Equity Research
Tyson Foods (TSN) Q3 performance will likely reflect gains from growing protein demand. However, a tight cattle supply environment might have been a spoilsport.
Post Holdings (POST) to Report Q3 Earnings: What to Expect?
by Zacks Equity Research
Post Holdings' (POST) value offerings, solid manufacturing and effective pricing strategies position it well for Q3 earnings amid escalated SG&A expenses and inflationary headwinds.
What Awaits for Pilgrim's Pride's (PPC) Q2 Earnings Release?
by Zacks Equity Research
Pilgrim's Pride's (PPC) Q2 performance will reflect gains from robust market momentum and improved efficiency. However, an elevated cost environment is a hurdle.
Service Corporation (SCI) Q2 Earnings Coming Up: Factors to Note
by Zacks Equity Research
Service Corporation's (SCI) second-quarter 2024 performance will likely reflect gains from strength in the Cemetery segment. However, a rising interest rate environment poses a threat.
Hershey's (HSY) Q2 Earnings in the Cards: Key Things to Note
by Zacks Equity Research
Hershey's (HSY) Q2 results are likely to reflect gains from brand strength, but high commodity costs, increased selling, marketing and administrative expenses and currency volatility are concerns.
Vita Coco Company (COCO) to Post Q2 Earnings: Things to Note
by Zacks Equity Research
Vita Coco Company's (COCO) second-quarter 2024 results are likely to reflect gains from brand strength and share in the coconut water category.
Archer Daniels (ADM) Gears Up for Q2 Earnings: Things to Note
by Zacks Equity Research
Archer Daniels' (ADM) second-quarter 2024 results are likely to reflect the impacts of tough market conditions and higher costs. A soft Nutrition segment is also a concern.
Will LAC Issues & Inflation Hurt Diageo's (DEO) FY24 Earnings?
by Zacks Equity Research
Diageo's (DEO) FY24 results are likely to reflect negative consumer sentiment and increased inventory levels in LAC, pressured further by escalating input costs.
What Awaits for Kimberly-Clark's (KMB) Q2 Earnings Release?
by Zacks Equity Research
Kimberly-Clark's (KMB) second-quarter performance is likely to reflect gains from brand strength and cost-saving efforts. However, cost inflation and supply chain volatility are a concern.
Will Philip Morris (PM) Top Estimates in Q2 Earnings Release?
by Zacks Equity Research
Philip Morris' (PM) Q2 results are likely to reflect gains from smoke-free products like IQOS and ZYN, along with efficient pricing amid elevated costs.
e.l.f. Beauty (ELF) Down 20% in a Month: Should You Buy the Dip?
by Vrishali Bagree
e.l.f. Beauty's (ELF) approach to adapting to consumer trends and enhancing operational effectiveness underscores its potential for recovery amid stiff competition and changing consumer preferences.
COTY Benefits From Focus on Growth Pillars Amid Cost Woes
by Zacks Equity Research
COTY benefits from a focus on strategic growth pillars and strong partnerships. However, challenges from a high-cost operating environment are a concern.
COTY on Track With Strategic Growth Pillars Amid High Costs
by Zacks Equity Research
COTY continues to stand out and is well-positioned to capitalize on this favorable market environment. However, it is operating amid a challenging geopolitical and macroeconomic environment.
Coty (COTY) Down 9.8% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Coty (COTY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks Industry Outlook Highlights Estee Lauder, Coty, Helen of Troy and European Wax Center
by Zacks Equity Research
Estee Lauder, Coty, Helen of Troy and European Wax Center have been highlighted in this Industry Outlook article.
4 Cosmetics Stocks Worth Watching Despite Industry Headwinds
by Ansuiya Mohta
The Zacks Cosmetics industry is grappling with rising costs and supply chain disruptions. Estee Lauder Companies (EL), COTY, Helen of Troy (HELE) and European Wax Center (EWCZ) are capitalizing on digital advancements and innovative strategies.